Abreos Biosciences, Inc.

9:15 AM - 9:30 AM (EDT), Tuesday, October 22, 2019 ・ 2nd Floor
Abreos Biosciences is planning to develop a novel therapeutic for treatment of multiple sclerosis, a chronic neurological disease. Our approach will be to study a well characterized biologic in a new indication facilitated by our platform for precision personalized dosing.
Company Type:
Company Website:
Company HQ State:
California
Company HQ Country:
United States
Year Founded:
2013
Main Therapeutic Focus:
Lead Product in Development:
Integrated Therapeutic for Multiple Sclerosis
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Not Provided